Lynparza/Imfinzi Regimen Is ‘Encouraging’ for Advanced Ovarian Cancer
In particular, the drug combination statistically improved average progression-free survival, which is the time patients live during and after treatment without their disease spreading or getting also plan to analyze overall survival (time from treatment until death of any…
Read More